Answers are grounded in this paper and cite their sources.
This review emphasizes that antibiotic prophylaxis for dental procedures should be restricted to high-risk cardiac patients, and that routine antiplatelet therapy can generally be continued during most dental surgeries.
Dental surgery is very common, and it is important for our dental colleagues to understand the medical history and chronic medications of our co-managed patients. Antibiotic prophylaxis is currently recommended only for patients at high risk for infective endocarditis when undergoing high-risk dental procedures. Good dental hygiene can prevent more infective endocarditis than prophylactic antibiotic therapy, as transient bacteraemia is common in daily activities such as the brushing and flossing of teeth. Most dental surgeries can generally be performed on patients taking a daily dose of aspirin, but the dentist must be able to assess the risk-benefit ratio of employing local measures of haemostasis versus stopping the antiplatelet therapy. Patients on antiplatelet with recent coronary artery stenting should be referred to their primary cardiologist regarding the cessation of these agents before any surgery.
No takes yet. Share an insight, caveat, or question.
FY et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: